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Piezoelectric surgery (PIEZO) uses ultrasonic vibration to cut hard tissue without 
damaging adjacent soft tissues. Our previous studies indicated that PIEZO enhanced bone 
turnover compared to a conventional rotary bur (BUR) in rat tibia wounds by inducing 
the regional acceleratory phenomenon (RAP). PIEZO induced osteocyte apoptosis 
without damaging blood vessels during Day 1, 3 and 7 of rat tibia healing. We 
hypothesized that PIEZO increased bone turnover by activation of osteocyte apoptosis 
with a controlled inflammatory response. This study evaluated early morphological 





Materials & Methods:  
We created surgical defects in tibia by either PIEZO or BUR in 9–10-week-old Sprague-
Dawley rat tibias (n=4). We evaluated tissue responses by using H&E, Masson’s 
Trichrome and TRAP stains on Day 1, 3 & 7 after surgery. The surgical defect beneath 
the soft tissue was located using Computed Tomography (CT).  
Results:  
On postoperative Day 1, there was no significant blood vessel change or cellular 
extravasation in the PIEZO group. In contrast the BUR group had extravasation of 
leukocytes and increased blood vessels' size. On Day3, there was no significant 
inflammation or morphological changes to blood vessels in the PIEZO group. Empty 
lacunae adjacent to the defect area suggested osteocyte apoptosis. In the BUR group, 
blood vessels returned to an average size and the leukocyte population was reduced and 
bone adjacent to the lesion was unaffected, and intact osteocytes were in  the lacunae. On 
Day 7 there was increased in osteoclastic activity in Piezo compared the BUR group. 
 Conclusion:  
These results suggested that PIEZO induced osteocyte apoptosis, increased bone turnover 
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Section 1: Background of surgical instruments and surgeries. 
 
Surgical methods and instruments have evolved over centuries. Increased understanding of 
bone healing played a major role in the evolution of  osseous surgeries in dentistry such as 
osteotomies, implant placement, graft surgeries and accelerated orthodontic movement. The use of a 
manual surgical chisel and mallets [1] was more traumatic and invasive and tended to inflict “benign 
proximal vertigo and dizziness” [1]. These procedures evolved to the more efficient and less 
traumatic “conventional method” using a rotary bur. This technique generates heat and can cause 
necrosis of surrounding bone/tissues during osseous surgery.  Irrigation with copious amounts of 
water or saline was used to prevent bony necrosis and subsequent delayed healing [2]. The rotary bur 
could result in of injury to neighboring tissues and teeth, and required supplemental pressure to 
oppose the rotation of the instrument [3]. In the beginning of the 20th century the use of “ultrasonic” 
devices using high frequency sound waves to cut hard dental tissues was implemented [4]. These 
devices decreased the risk of damage to surrounding soft tissues and important structures such as 
nerves, vessels, and mucosa [4].Piezoelectric devices using the ultrasonic technique are safe and 
efficient for osteotomy or osteoplasty compared to traditional rotary instruments because of the lack 
of “macrovibratons” and the ease of control and increase in safety in cutting in intricate anatomical 
areas [4]. In the 21st century the Piezotome (Piezoelectric knife-based off ultrasonic waves) was used 
more frequently in orthodontics, maxillo-facial, endodontics and periodontology as an alternative to 
the conventional rotary bur.  
In 1988 Dr. Vercellotti developed the novel technique of “Piezosurgery” to overcome the 





Lobene and Glickman [3] reported up to 1.7 mm of alveolar bone loss following osseous surgery in 
animal studies. Wilderman et al [3] investigated the reparative potential of tissue following 
mucogingival flap or osseous surgery in human patient and they recorded minimal initial bone 
resorption ranging from 0.14 to 4.47 mm (Avg. of 1.2 mm) followed by alveolar regeneration 
between 0.14 to 1.15 mm (avg. 0.8mm). The initial bone thickness was noted as an important 
determinant of the amount of postoperative bone loss. Thicker bone with marrow spaces exhibited 
less bone resorption and greater repair when compared to thin bone [3]. In 2005 Vercellotti et al [3] 
used piezoelectric instruments vibrating in the ultrasonic frequency range in periodontal resective 
therapy. Postoperative wound healing was measured at 14, 28 and 56 days after surgery and the 
efficacy of Piezosurgery (PS), Carbide Bur (CB) and Diamond Bur (DB) were compared. CB or DB 
treated groups lost bone compared to bone gain from PS on day 14. On Day 28 all groups had bone 
gain. On day 56 the PS group had more bone gain in compared to CB and DB. Thus, piezosurgery 
was associated with more favorable osseous repair and remodeling than CB or DB following surgical 
ostectomy and osteoplasty procedures [3].   
The conventional rotary drill and piezoelectric devices were compared in preparing bone for 
implant surgery. In 1975, Horton et al. [6] in an experiment in dogs demonstrated that the use of 
ultrasound was less traumatic than rotary instruments and allowed for precise bone removal and 
controlled bleeding [7].  In 2007 Preti et al. [7] compared the degree of inflammation, bone healing 
and remodeling for days 7,14, 28 and 56 around titanium implants placed in the tibia with either a 
traditional drill or a piezoelectric surgical device. The bone around piezoelectric surgery sites had 
earlier increases in BMP-4(bone morphogenetic protein-4) and TGF-β2 (Transforming Growth 
Factor) bone repair protein levels and reduced expression of proinflammatory cytokines. In the early 





neo-osteogenesis and osteoblasts compared to drilled sites which were observed at 56 days. The 
expression of earlier bone morphogenetic proteins controlled the inflammatory process more 
effectively [7]. 
Wilcko et al [8] in the early 21st century suggested that rapid tooth movement associated with 
corticotomy-facilitated orthodontics was likely the result of demineralization/remineralization 
processes, with increased osteoclastic activity. Wilcko et al and Ferguson et al [8] combined “bone 
activation” (selective decortication via bur and bone thinning with no osseous mobilization), alveolar 
augmentation using bone grafting material and orthodontic treatment, which was referred as 
accelerated osteogenic orthodontics (AOO). Sebaoun et al [8], in a rat model, reported that selective 
alveolar decortication resulted in a 3-fold increase in catabolic and anabolic processes. AOO 
enhanced the scope of malocclusion treatment (i.e. decrease in the need for tooth extraction and the 
ability for more movement of teeth), decreased treatment time, increased alveolar volume and a more 
favorable periodontium and alveolar reshaping for an enhanced patient profile. [8]  
 In 2009 Dibart et al. [1] introduced the novel technique of “Piezocision”, was a concept based on 
surgically accelerated orthodontics using the piezoelectric knife in a minimally invasive surgery in 
conjunction with orthodontic movement. The Piezoelectric knife is inserted through an interproximal 
micro-incision to a depth of approximately 3 mm between the roots of the teeth, without reflection of 
a full-thickness flap [1] [9]. The resulting bone injury resulted in a process known as regional 
accelerated phenomenon (concept outlined by Frost in 1983), which accelerated tooth movement. If 
there is inadequate bone or tissue support, a tunneling technique along with soft or hard tissue grafts 
can be considered. Activation of the regional accelerated phenomenon (RAP) accelerates osteoclastic 
catabolic activity and stimulates new bone formation (via osteoblasts). “Piezocision” reduces the 





activity occurs as early as day 1 and proceeds to RAP. The procedure effectively reduces the lag 
phase for orthodontic tooth movement.  Histologically, increased osteoclastic activity occurs when 
“piezocision” is combined with tooth movement compared to tooth movement alone. Piezocision 
leads to more rapid and extended bone resorption, increased numbers of osteoclasts, inflammatory 
macrophages and dendritic cells starting from day 1. “Piezocision” stimulates alveolar bone turnover 
via increased early osteoclastic activity [1].   
The methods outlined above by Wilcko et al. [8] and Dibart et al. [1] are currently used in clinical 
treatment of patients. The concepts are similar with increased catabolic and anabolic tissue responses 
and both methods reduced the treatment time by means of “selective decortication” by the bur or the 
piezoelectric knife. The two different methods have not been compared at a cell activity level.  
Studies of the rotary bur and the piezoelectric surgery were also compared in osteotomies in third 
molar extractions. The rotary bur handpiece impairs healing and leaves irregular surfaces on bone 
and marginal osteonecrosis due to overheating of bone and damage to adjacent tissues [11] [12]. The 
two methods were compared in a blinded study with a “Split-mouth method” for postoperative 
effects such as pain, swelling, and trismus. Post-operative days 1, 3, 5, 7 and 15 were evaluated for 
swelling, pain, and maximum inter-incisal opening of the mouth. Pain was assessed by a 10 mm 
visual analogue scale (VAS) with “0” being no pain and 10 being the most severe pain. All patients 
showed uneventful soft tissue healing with no infection. Piezosurgery is minimally invasive and is 
optimal for protecting the surrounding soft tissues and important structures such as nerves, vessels, 
mucosa, and bone. The rotary procedure showed greater facial swelling compared to the piezoelectric 
surgery in all postoperative times, but especially at day 3 [11]. The piezoelectric tip is highly 
advantageous in that it minimizes damage to soft tissues and leads to significantly faster post-





cavitation phenomenon, an implosion of gas bullae into blood vessels during osteotomy, which 
produces a hemostatic effect and reduces blood loss. Piezoelectric surgery increases bone density 
within the extraction socket and decreases bone loss along the distal aspect of the mandibular second 
molar. The piezoelectric knife cuts like a chisel rather than burnishing which occurs with a rotary bur 
[11]. Scanning Electron Microscopy (SEM) studies have demonstrated an irregular surface in 
surgical fields from the rotary bur handpiece compared to a clean surface immediately covered with 
fibrin with piezo surgery.  Piezosurgery is a better alternative to the rotary technique in terms of 
postoperative outcomes for pain, edema, and trismus despite the increased surgical duration [12]. 
  In addition to studies determining which surgical method is better suited to clinical practice, 
there is a question as to the mechanism of repair with each technique. The conventional bur/ drill is 
faster compared the piezoelectric device, but the piezoelectric surgery “activated” the repair 
mechanism at an earlier stage and shortened the time required to regenerate bone. The biology of 
bone at a cellular level needs to be correlated with a histological analysis to gain a better 
understanding of the effect of the two different instruments and the magnitude of activation by the 












Section 2: Bone  
 
Bone is a complex and dynamic tissue that continually adapts to different conditions throughout a 
lifetime. Bone maintains its structural integrity through many cellular mechanisms, acts as a site of 
hematopoiesis, a source for minerals (calcium, and phosphate) and is necessary to regulate mineral 
homeostasis. Bone consists of cellular components including osteocytes, osteoblasts, and osteoclasts, 
whose interplay has a major role in maintaining the structural integrity of bone and maintain a state 
of homeostasis. When bone sustains a disruption of its structural integrity (i.e. injury, fracture, 
osteotomies or an osseous surgical procedure to prepare a graft recipient site) it goes through a 
complex process to re-establish to a state of “normality”. Bone repair will undergo five phases in 
order to return to homeostasis [13]: 





Each of these stages is dependent on the prior stage for success, but it is necessary to understand the 











2.1: Cellular components involved in bone. 
 
➢ Osteocytes 
Osteocytes are the most abundant cells in mineralized bone [14]. They are derived from 
mesenchymal stem cells and were bone forming osteoblasts that became embedded within the bone 
matrix during calcification of the osteoid [15]. They can be considered one of the terminal stages of 
osteoblasts. Within the bone’s mineral matrix, the osteocyte is encased in a fluid -filled space known 
as a lacuna. They are connected to each other, adjacent cells and the bone surface via long cellular 
processes which extend into channels called canaliculi [16] [15]. The cellular processes in the 
canaliculi are filled with fluid and possess the capability of moving molecular and ionic particles 
along this “lacuna-canalicular” system [17]. The connections between the osteocytes and the bone 
matrix through the canaliculi play an important role in mechanosensing. This allows the bone to 
adapt to a changing mechanical environment [18]. Mechanical stimuli can activate the mechano-
sensor properties of osteocytes from hydrostatic pressure, fluid shear stress or direct deformation 
which influences osteocyte function [15]. When the osteocyte mechanosensory system recognizes 
the stimulus, it transmits signals to the neighboring osteocytes. This stimulus also plays a crucial role 
in activation of osteoclastic bone resorption and remodeling of the damaged site. Osteocytes that 
undergo apoptosis secrete osteoclastogenic factors that stimulate the osteoclast precursors to 
differentiate into osteoclasts and initiate bone resorption in bone remodeling. The process of bone 
remodeling can be controlled by osteocytes by secretion of growth factors such as Transforming 
Growth Factor-β (TGF-β). The life span of the osteocyte is approximately two decades, the cell may 
die by apoptosis (the cell undergoes contraction, loses contact with neighboring cells, and break up 
into apoptotic fragments that are phagocytosed), necrosis (through an inflammatory process) or just 






Osteoblasts are “bone forming” cells and are derived from mesenchymal stem cells [19] [20].  
Osteoblastic cells include immature osteoblast lineage cell (pre-osteoblasts) and differentiating mature 
matrix producing osteoblasts [13].These cells express parathyroid hormone (PTH) receptors and play 
an important role in the bone remodeling process. Osteoblasts in bone remodeling express 
osteoclastogenic factors, secrete bone matrix proteins such as type I collagen (90% of matrix proteins) 
and bone morphogenic protein (BMP) and mineralize bone [13]. The differentiation of these cells is 
regulated by runt-related transcription factor 2 (RUNX2) also known as core-binding factor 
A1(CBFA1) [13]. Runx2 upregulates osteoblast-related genes such as collagen type I alpha 1 
(ColIA1), alkaline phosphatase (ALP) bone sialoprotein (BSP) and osteocalcin (OCN). When 
proliferating osteoblasts differentiate from pre-osteoblast (osteoblast progenitor cells) there is 
expression of Runx2 and ColIA1 and an increase in ALP activity. The pre-osteoblast transition to 
mature bone increases secretion of OCN, BSP and collagen type I. The bone matrix synthesis via 
osteoblasts occurs in two steps: 1) deposition of organic matrix and 2) mineralization of the matrix 
[19].  The life span of osteoblasts are approximately two weeks and the fate of the osteoblast can 
ultimately be terminally differentiated to an osteocyte, becoming a bone lining cell or undergo 
apoptosis [21]. 
 
➢ Bone Lining Cells 
The bone lining cells are relatively inactive flattened cells that cover the bone surface and are not 
active in bone formation or resorption. These cells form a continuous layer along the bone surface to 
form an endosteal layer adjacent to the hematopoietic tissue in the bone marrow. Some of these cells 





junctions are present between the adjacent bone lining cells and osteocytes [19]. The true function of 
bone lining cells is not known and depending on the physiological state of the bone these cells can 
regain their secretory potential and become active osteoblasts [22] [21].  Bone lining cells act as a 
barrier between osteoclasts and the bone matrix protecting it during inhibition of bone resorption. They 
influence osteoclast differentiation by producing osteoprotegerin (OPG) and activator of nuclear factor 
kappa-B ligand (RANKL) [19]. The bone lining cells maybe capable of contributing to bone formation 
in the absence of osteoblasts (ablation of osteoblast stimulus) [21]. 
 
➢ Osteoclasts 
Osteoclasts are known as “bone resorbing” cells that are terminally differentiated from the 
hematopoietic stem cell lineage (myeloid cells) [23]. The main function of osteoclasts is to resorb 
mineralized bone matrix and calcified tissues [24]. The differentiation of osteoclasts is dependent 
upon several factors, including macrophage colony-stimulating factor (M-CSF) secreted by 
osteoprogenitor cells and osteoblasts and RANKL from osteocytes and osteoblasts. RANKL is a 
crucial factor for osteoclastogenesis, as RANKL binds to RANK receptor on the precursor osteoclast 
to promote differentiation [19] [13]. Osteoprotegrin 2 (OPG2) which is also produced by osteoblasts 
and stromal cells, acts as a decoy receptor for RANKL and thus is a negative regulator of osteoclast 
differentiation [13]. Osteoclasts are predominantly present during physiological bone remodeling and 
wound healing. In bone remodeling process osteoclasts become polarized with four membrane 
domains: 1) sealing zone, 2) ruffled border that is in contact with bone matrix, 3) basolateral domain 
and 4) functional secretory domain in which the last two mentioned are not in contact with the bone 
matrix [19]. Besides being a bone resorbing cell, the osteoclasts secrete cytokines that influence 






Chondrocytes are cartilage forming cells derived from the mesenchymal stem cell lineage. The 
mesenchymal stem cells for chondrocytes in endochondral bone reside in the periosteum of the bone 
[25]. These cells are found in endochondral bone and play an intermediate role in endochondral bone 
ossification [26]. The mesenchymal stem cells undergo condensation and give rise to pre-
chondroblasts [26], which hypertrophy and along with neovascularization form a bone collar. A 
primary ossification center and primary spongiosa forms later and the cartilage matrix is replaced 
with bone [26]. Lastly, there is a formation of a secondary ossification center leaving a line of 
chondrocytes, the metaphysis or epiphyseal growth plate and elongation of the bone. This bone will 
undergo modeling via periosteal apposition and endosteal resorption, which is responsible for 
attaining its genetically determined shape.  
 
➢ Endothelial cells and blood vessels 
Blood vessels are essential for adequate osteogenesis, and communication between endothelial 
cells and osteoblasts is essential as well.  A mechanism known as notch signaling promotes the 
proliferation of endothelial cells and vascular growth in bone [27]. If the notch signaling is disrupted, 
blood vessel growth is impaired which reduces osteogenesis, produces chondrocyte defects and 
potential loss of bone mass. The network of vessels in bone provides nutrition and acts as a pathway 
for transmission of chemical signals and expression of cytokines, may lead to an inflammatory 
response.  In response to inflammation the blood vessels dilate and become leaky, to allow 
extravasation of fluid and inflammatory cells to the site of injury. It is important for the bone to have 






➢ Inflammatory cells  
If a bone sustains injury, intentionally by surgical intervention or through fracture, an 
inflammatory response will be initiated to invoke healing. This inflammatory response entails the 
recruitment of leukocytes such as polymorphonuclear leukocytes (PMNs) and monocytes to the site 
of injury. The damaged tissue releases chemo-attractants including leukotrienes, cytokines, 
chemokines and exogenous chemo-attractants to initiate this inflammatory response. Neutrophils are 
recruited to the inflammatory site to engulf damaged tissues; the neutrophils are cleared from the site 
by apoptosis and macrophage clearing [18]. An inflammatory response can be considered as an 
essential step for activation of the bone remodeling process. 
 
➢ Megakaryocytes 
Megakaryocytes are derived from hemopoietic stem cells in bone marrow and produce platelets 
that are necessary for blood clotting.  They have the capability of directing resorption and formation 
of bone by enhancing the proliferation and differentiation of osteoblasts and secrete a soluble anti-
osteoclastic factor [13].  
 
➢ Mesenchymal Stem Cells (MSCs) 
Mesenchymal stem cells are undifferentiated multipotent cells that have the capability to form 
specialized cells and recruit other cells [28].  The cells can be delivered through existing vasculature 
and may be recruited to bone, adjacent tissues such as muscles, tendon, and adipose tissue. For bone, 
these cells can be derived from the periosteum, bone marrow and the endosteum. The periosteum and 
bone marrow are the main source of skeletal stem cells/progenitors for bone formation or repair. 





deposition of cartilage and bone at the site of injury [25]. When the periosteal surface is injured, 
healing occurs by endochondral ossification. When the bone marrow is injured, healing occurs by 
intermembranous ossification. Osteogenic and chondrogenic potentials of periosteum and bone 
marrow/endosteum may be defined by a distinct stem cell progenitor within these specified tissues. 
The mesenchymal cells from the periosteum differentiate into chondrocytes which will lay down 
cartilage that will eventually be replaced by bone [29] [25]. The mesenchymal stem cells that 
originate from the bone marrow/endosteum differentiate into osteoblasts. If the periosteum is 
damaged or removed, it affects osteogenesis or chondrogenesis and delays wound healing. An 
overzealous mechanical disruption of the bone marrow delays healing, probably due to depletion of 
MSCs and disrupting the inflammatory response [25]. 
 
2.2: Biochemical elements in bone 
 
Bone has a complex array of biochemical factors, including growth factors, factors to 
influence stem cells, ligand–receptor binding, cytokine secretion, production of proteins and 
proteases. These elements play a crucial role in osteogenesis, osteoclastogenesis and wound healing. 
Briefly some of the relevant biochemical elements involved in bone are: 
 
➢ Transforming Growth Factor (TGF-β)- Osteocytes express TGF-β, which stimulates bone 
formation by causing proliferation of osteoblast precursors [25]. When osteocytes undergo 
apoptosis there is a decrease in expression TGF-β [13] , which stimulates an increase in 
osteoclast stimulating factors. TGF-β also plays a role in negative feedback for 
osteoclastogenesis [14], where an increase of its expression leads to the suppression of 





➢ Bone Morphogenetic Protein (BMP)- This protein was first discovered and isolated by M. 
Urist in the mid – 1960s as “bone induction principle” later named as bone morphogenetic 
proteins [30]. The BMP group has many members, specifically BMP-4 contains many 
proteins that induce bone formation [7]. BMPs act as regulators of osteoblasts and 
chondrocyte differentiation during bone development and osteogenic differentiation during 
the healing process in bone. BMP activity may be stimulated by growth factors such as, 
fibroblast growth factors, TGF-β and platelet-derived growth factors [7]. 
➢ Nuclear factor kappa-B receptor and ligand (RANK and RANKL)- RANK is a member 
of the TNF receptor superfamily which plays a role in activation of T-cells in the immune 
system. RANKL is a type II homotrimeric membrane bound transmembrane protein that is 
expressed [31].  RANKL is expressed by osteoblasts [32] and RANKL/RANK binding 
stimulates differentiation of multinucleated osteoclasts from precursor cells [31]. RANKL-
induced osteoclast activation may regulate progenitor recruitment as a response to maintain 
homeostasis or host defense [31]. 
➢ Osteoprotegrin (OPG)- OPG is expressed in osteoblasts [31] and is a soluble decoy receptor 
for RANKL and a negative regulator of osteoclastogenesis. Loss of function of OPG results 
in osteoporosis due to excessive osteoclastogenesis [13]. Therefore, OPG protects the 
skeleton from excessive bone resorption by binding to the RANKL, preventing binding to the 
RANK receptor [31]. 
➢ Tumor Necrosis Factor (TNF) and TNF-related activation-induced cytokines 
(TRANCE)- TNF-α is a proinflammatory cytokine [7] and is one of the final steps in 
osteoclast formation [32]. At sites where inflammation occurs there will be a higher 





development and homeostasis. TRANCE is expressed on activated T cells and activates 
mature dendritic cells. It mediates T cell-dendritic cell interactions during an immune 
response [33]. TRANCE is also known as osteoclast differentiation factor (ODF). When 
TRANCE is expressed on osteoblasts along with other factors it induces osteoclastogenesis 
and osteoclast differentiation leading to bone resorption [33]. It can be inhibited by OPG by 
binding to its receptor. 
➢ Parathyroid Hormone (PTH)- This is a calciotropic hormone that maintains calcium 
homeostasis [13] [20]. PTH is secreted by the parathyroid glands in response to reduced 
serum calcium. There are PTH receptors present on osteoblasts, once it binds PTH it will 
induce osteoclastic differentiation and activation of bone resorption to increase the serum 
calcium levels [13]. 
➢ Colony Stimulating Factor or Macrophage Colony Stimulating Factor (CSF or M-CSF)- 
Is a hematopoietic growth factor which stimulates the survival, proliferation, differentiation, 
and various functions of cells from the mononuclear phagocyte lineage [34]. It plays a role in 
bone metabolism, inflammatory responses and is a critical stimulating factor which entails 
the survival and activation of osteoclasts after osteoclast progenitors differentiate into 
osteoclasts [32]. Both TNF-β and interleukins can stimulate the production of M-CSF by 
monocytes, epithelial cells, fibroblasts, T-cells and PMNs [34]. 
➢ Matrix metalloproteinases (MMPs)- MMPs have more than 20 members in their family. 
They consist of a catalytic domain, a pro-peptide domain and a regulatory C-terminal 
domain. MMP-9 and MMP-14 are present in osteoclasts, and act to solubilize bone matrix 
[35]. MMP-13 is secreted by osteoblasts in response to mechanical and endocrine remodeling 





the RGD binding adhesion site. The osteoclasts bind to the site and cause dissolution of the 
mineral matrix which produces the Howship’s resorption lacunae [13]. 
➢ Runt-related transcription factor 2 or Core-binding factor A1 (RUNX2 or CBFA1)- 
These are the master transcription factors controlling osteoblast differentiation [20]. A lack of 
RUNX2, will result in loss of mineralized tissue due to the cessation of osteoblast 
differentiation [13]. Thus, the lack of RUNX2 can lead to osteoporosis. 
➢ PU.1 Transcription Factor – Is an ETS domain (DNA binding protein) transcription factor. 
During early myeloid cell differentiation, it is essential for development of osteoclasts and 
other myeloid lineage cells [13]. 
➢ Nuclear factor of activating T-cells cytoplasmic 1(NFATc1)- Is the factor that makes the 
terminal osteoclast differentiation and functions by acting as a critical switch for 
osteoclastogenesis [13]. 
➢ Interleukin-1β and Interleukin-10 (IL-1β and IL10)- Interleukins are cytokines that are 
part of innate and adaptive immunity and are expressed during an immune response. IL-1 is 
an important hematopoietic factor that induces expression of colony stimulating factors on 
progenitor cells, leukocytes, and stromal cells. When IL-1 is induced during acute 
inflammation it upregulates adhesion sites on endothelial and immune cells for infiltration of 
leukocytes to the area of damage [36]. IL-10 is a cytokine with anti-inflammatory properties 
that limits an immune response to pathogens. T-cells and macrophages can regulate IL-10 
cytokine expression [37].  Therefore IL-1β is a pro-inflammatory cytokine that orchestrates 







2.3:  Bone remodeling and repair 
The disruption of bone integrity (intentional or unintentional) initiates normal “healing” by 
two mechanisms: a) sensitizing the surviving cells to respond to the local and systemic messengers 
(i.e. osteoclasts, osteomacs (resident tissue macrophages [38]) and other macrophages [39]) and b) 
release of local biochemical and biophysical messengers that control cellular responses such as, 
mitogens for proliferation and differentiation [24]. The role of osteoclasts is to resorb mineral and 
bone matrix. They have unique characteristics that help identify them, such as multinuclearity, 
expression of tartrate-resistant acid phosphatase (TRAP) and calcitonin receptors. Osteoprotegerin 
(OPG-a negative regulator of osteoclastogenesis), RANKL(receptor activator NF-κB ligand), CSF-1 
(colony stimulating factor-1)or M-CSF (macrophage colony stimulating factor) are necessary 
cytokines for survival, expression and differentiation of osteoclast precursor cells in vitro and 
osteoclastic bone resorption activity in vivo [13] [18].  Tissue injury may cause an acute 
inflammatory response which will recruit leukocytes (PMNs) to the site of injury by sensing the 
chemo-attractants (i.e. leukotrienes, cytokines, chemokines and exogenous chemo-attractants) 
released by the damaged tissue. Neutrophils are recruited to the inflammatory site to engulf damaged 
tissues; the neutrophils are cleared from site by apoptosis and macrophage clearing [18].  The 
disruption in the integrity of the bone must be sufficient to initiate a phenomenon of RAP (regional 
acceleratory phenomenon) which increases healing. Once evoked processes such as perfusion, 
growth of bone and cartilage are two to ten times faster [40] [24]. The RAP is similar to an “SOS” 
type phenomenon which potentiates the survival of the species in a physical competitive 
environment (for example the bone injury- being the competitive environment and the progression to 





Once the precursor cells are sensitized and stimulated, local mediator mechanisms produce 
cells that differentiate to new fibroblasts, lipoblasts and supporting cells (mast cells and leukocytes). 
In addition, intercellular collagen fibers and ground substance blood vessels(neovascularization) are 
also produced [24].Bone remodelling is performed by clusters of bone resorbing osteoclasts and bone 
forming osteoblasts arranged within a temporary structure known as the “basic multicellular unit” 
[13]. The BMU produces the osteoclasts that remove pre-existing hard tissues and then produces the 
osteoblasts to synthesize new bone (activation-resorption-formation sequence) [24]. Osteoblasts 
develop from pluripotent cells and express osteoclastogenic factors (i.e.- via proinflammatory 
cytokines or the RANK/RANKL [23] and OPG system), production of bone morphogenic protein 
(BMP) and control bone mineralization [13].  
 Bone remodeling requires the detection of initiating signals via the osteocytes at the site of 
injury.  Damage to the bone matrix results in osteocyte apoptosis and increased osteoclastogenesis.  
The osteocytes normally secrete transforming growth factor β (TGF-β), which inhibits 
osteoclastogenesis.  The focal apoptosis of osteocytes lowers the TGF-β levels, which removes the 
inhibitory osteoclastogenesis signals and allows osteoclast formation [18]. During the resorption 
phase, osteocytes generate signals to recruit osteoblasts, which produce a chemokine MCP-1 
(monocyte chemoattractant protein-1), that acts as a chemoattractant for osteoclast precursors and 
increases RANKL-induced osteoclastogenesis. The osteoblast precursors, osteoclast precursors, 
osteoclastogenesis cytokines, CSF-1, OPG and RANKL modulate the bone remodeling. Howship’s 
lacunae are covered with undigested demineralized collagen matrix.  Mononuclear cells remove 
these collagen remnants and prepare the bone surface for the osteoblast-mediated bone formation or 
“reversal phase”. The osteomacs are thought to be responsible for removal of the matrix debris 





resorption to bone formation with in the BMU. During the “formation phase”, TGF-β is a key factor 
induced by the coupling signals to recruit mesenchymal stem cells to the site of bone resorption. 
Once the mesenchymal stem cells or early osteoblast progenitors have reached the resorption 
lacunae, they differentiate and secrete collagen type I and non-collagenous proteins that are an 
integral part of bone. These include proteoglycans, glycosylated proteins (i.e. nonspecific alkaline 
phosphatase), small integrin-binding ligand proteins and Gla-containing proteins (matrix Gla protein 
and osteocalcin). Tissue nonspecific alkaline phosphatase, nucleotide pyrophosphatase 
phosphodiesterase and progressive ankylosis, generate optimal extracellular concentration of 
inorganic phosphate, which allows mineralization [13]. 
Bone remodeling will precede to the “termination phase” in which equal quantities of 
resorbed bone has been replaced [13], bone will recontour into its overall normal shape, this 
reshaping or sculpting is known as modeling. The “mini-modeling” processes on trabeculae inside a 
bone can realign it to be parallel with major mechanical loads [24].  
 
2.4: Regional Acceleratory Phenomenon 
The regional acceleratory phenomenon (RAP) was first described by H.M Frost [40].  RAP is 
a complex reaction of mammalian tissues to many different noxious stimuli. The phenomenon occurs 
regionally involving hard and soft tissues and is characterized by acceleration of normal vital tissue 
processes as an “SOS” phenomenon of the body to the new perturbation [40].  Once evoked, it will 
affect ongoing regional soft and hard tissue vital processes including perfusion; growth of skin, bone, 
cartilage, and hair, turnover of bone, cartilage, synovial fluid, connective tissue, and fibrous tissue; 
bone and chondral modeling, soft tissue and bone healing and cellular metabolism [40]. The 





healing process anywhere from “ten to fifty-fold” [40]. The causes of RAP are numerous and 
depends on the anatomy and competence and innervation of the regional blood supply, regional 
sensory innervation, and mechanical loading as well as the biochemical and biological factors 
associated with injury, repair, and inflammation. The basic differences in causative factors rely on 
the magnitude and type of infliction, which may characterize soft and hard tissue RAPs and 
accounting for differences in microscopic appearance [40].  Activation of RAP accelerates the 
process of osteoclast catabolic activity and the turnover of apposition for new bone stimulation (via 
osteoblasts) [1]. The BMU (basic multicellular unit), which produce the osteoclasts that remove 
packet of pre-existing hard tissues and then produce the osteoblasts that replace it with new bone 
(activation-resorption-formation sequence) [24]. 
 
 
2.5: Piezoelectricity of bone 
“Piezoelectricity” is derived from the Greek words “piezo” and “elektron” which means 
“electricity resulting from pressure [41].  Bone generates electricity under pressure and this 
electromechanical behavior is thought to be essential for bone regeneration and remodeling. 
Collagen is the main structural protein in bone and is known as a piezoelectric element [42]. When 
collagen containing tissues are deformed it generates an electric potential [43]. The deformation of 
the bone matrix changes the surface potential and increases the pressure in the canalicular fluid. The 
flow of the lacunocanalicular fluid can be considered as the movement of various molecular and 
ionic particles [17]. This increase in pressure induces apoptosis of osteocytes which is the first step 
for bone regeneration. When osteocytes die, they release chemical trigger signals to the osteoclasts to 





matrix [42]. The electric field created by the piezoelectric elements attract ions creating an 
electrochemical gradient that assists osteogenesis, therefore speeding repair of the damaged tissue 
[42].  Piezoelectric stimulation (20-60 mv) can up-regulate transcription of TGF-β1 growth factor 
[44]. Hence a suitable or optimal deformation of the piezoelectric bone matrix can affect the 
lacunocanalicular fluid flow for the activation and acceleration of bone remodeling by promoting 
higher osteoblast adhesion and proliferation [17]. 
 
 
Section 3: Digital Dentistry 
Radiographs have been used in dentistry to help with diagnosis and treatment planning for 
patients. Throughout the 20th century [45] x-rays were 2-dimensional images that were used for 
diagnosis of carious lesions and bony defects. The shortcoming of the conventional x-ray was lack of 
resolution leading to blurring of important anatomical structures and the need for multiple x-rays, 
hence increase in exposure of the patient to radiation to capture multiple regions. In the 21st century, 
cone beam computed tomography (CBCT) was introduced [45], as a radiographic imaging method 
that allows accurate, three-dimensional (3D) imaging of hard tissue structures and provides 
volumetric data in axial, sagittal and coronal planes. The technique consists of the use of a round or 
rectangular cone shaped X- ray beam with a single 360° scan. The X-ray source and a reciprocating 
array of detectors move around the object being scanned. Projection data is created and compiled to 
recreate a 3D volumetric data set in the 3 planes by compatible software. The radiation exposure in 







Section 4: Sprague Dawley Rats 
Small animal models such as rats are used in medical research  to improve knowledge of 
methods and procedures before clinical applications in human beings.  Rats have been used to study 
biological questions in pathological and physiological sciences for more than 150 years [47]. Rats 
have a similar genome to human beings, where the physiology corresponds to human, and the rats 
have a shorter lifespan (~4years) making it an ideal model to study physiological events in a human’s 
lifetime over 120 years of age [47]. For a comparative timeline; rats reach musculoskeletal maturity 
in ~ 7 months which is observed at 20 years of age in humans, the protein turnover is ~10 times 
faster, basal metabolic rate is ~ 6.4 times faster and inflammatory response is ~ 30-50 times faster 
[48], hence 1 rat day would be ~ 27 human days or ~ 13.5 days is equal to 1 human year [48] . The 




















We hypothesize that initiation of biological responses related to bone resorption and bone 
regeneration in response to deep penetration by Piezo and Bur, will cause a more profound response 
in the remodeling process than shallow penetration. In addition, Piezo will increase the turnover bone 
healing in both shallow and deep defects compared to the Bur. The magnitude and area of activation 
created by piezo will also be greater than that of the bur.  Piezo will also induce more apoptosis 
compared to the bur and Piezo penetration will also create a piezoelectric effect in the canaliculi [17] 




The aim of the study is to compare the biological response and effect of the surgically created 





      MATERIALS AND METHODS 
➢ Experimental groups 
A total of 24 male rats (Sprague-Dawley) 300-330 g between 9-10 weeks will be divided into 6 
experimental groups.  
1) Deep penetration of tibia with a (BS1) piezoelectric knife (n= 4) 
2) Deep penetration of the tibia with a rotary carbide bur (n=4) 
3) Shallow penetration of tibia with a piezoelectric knife (n=4) 
4) Shallow penetration of tibia with a rotary bur (n=4) 
5) Sham group (n= 4)  
6) Control group. (n=4)  
Note: The control group will have no surgical intervention and the sham group will have an 
incision to the periosteum, reflection of a flap, no penetration on the bone and sutured back. 
All procedures were approved by Boston Medical Centre Institutional Animal Care and Use 
Committee (BUMC IACUC # PROTO201800477). 
➢ Surgical Procedure 
The rats were sedated with an intraperitoneal injection of Ketamine (80mg/kg) and Xylazine 
(10mg/kg). The administration of 0.3mg/kg of sustained-release buprenorphine subcutaneously 
for pain control. The leg was shaved and disinfected with 70% ethanol before a full thickness 
incision was made with a no.15 blade (Bard-Parker) along the midline of the tibia.  
After reflection of the full thickness flap the surgical procedure was done: 
• Deep transcortical penetration of tibia with a (BSL1) piezoelectric knife [(Piezotome 2-
Acteon-Satelac) (approx~30 kHz). 





• Shallow penetration of tibia with a piezoelectric knife without penetrating cortical bone. 
• Shallow penetration of tibia with a rotary bur without penetrating cortical bone. 
• Control group with no surgical intervention. 
• A sham operation (Sham group) will be performed on the opposite tibia to the control 
group. In the sham surgery a full thickness flap will be reflected and sutured back (no 
intervention to cortical bone). 
After completion of the surgical procedure, horizontal mattress sutures with 4-0 Polyglycolic 
acid (PGA) (Ace Surgical) were placed to reapproximate the borders of the wound. Full closure 
was attained with three interrupted sutures with 5-0 PGA (Ace Surgical). Rats were monitored 
and weighed daily, until they were euthanized. 
➢ Post-surgical procedure 
The rats were sacrificed on Day 1, 3, and 7. The rats were euthanized with carbon dioxide and 
blood was collected from the heart. The skin on the leg was removed, and the leg was dissected 
from the acetabulo-femoral joint and preserved in 10% neutral buffered formaldehyde solution in 
a 50 ml Falcon Tube. 
➢ Determining the region of interest post-surgical intervention 
A histological analysis of the tissues was done at intervals 1, 3, and 7 days. The surgical 
intervention was performed away from the primary incision site to avoid the infection of the 
region of interest (ROI). Since the overlying tissue (muscle and periosteum) is left intact, 
inhibiting a clear picture of where the intervention was done. A series of CBCTs (iCAT) with 
8x8cm voxel, 0.125 resolution, and 120K was performed. The CBCT analysis was used in hopes 
to optimize the localization of the ROI. A primary CBCT(CBCT1) will be taken after a reference 





holding device to accommodate the falcon tube (Fig.1A). The specimen is centered according to 
the laser and assured that the tube is leveled, this was confirmed with leveling the base along with 




Figure 1:Representation of Primary CBCT: 
 A. Represents the iCAT CBCT machine and the placement of the holder and the falcon tube with 
specimen. B. Represents the “assumed ROI line that is being scanned for the primary CBCT. C. 
The level to confirm the base and holder is leveled. D. The level placed on the top of the falcon 











The Primary CBCT (CBCT1) was analyzed using InVivo 6 Anatomage software, with the 
“sections” setting, to determine the accuracy of the “assumed ROI” location. The sample will be 
rotated in the axial plane till the ROI is visible at the sagittal view on the program (fig. 2B). We 
noted the rotation needed to prepare the specimen for the confirmation CBCT keeping in mind 
the XYZ plane (Fig. 2A) (X plane is transverse, Y plane is sagittal, and the X plane is the axial 
direction). The use of an angle rotation device (Fig. 2C &D) was used to translate the analysis of 
the rotation necessary to the physical sample in the falcon tube. The confirmation CBCT analysis 
of the angle of rotation will assess the “Actual ROI” site, which was marked as a new reference 
line (in red) (Fig.2D) on the specimen tubing. A secondary CBCT for confirmation (CBCT2) and 
tertiary CBCT confirmation (CBCT3) was done if we could not confirm the accuracy of the 
translation of the new reference line in relation to the ROI, which a new angle of rotation was 
translated from the software physically on to the tubing for assessment. The confirmation CBCT 
was taken the same way as the primary CBCT where the sample in the tubing was placed on the 
holder, ensuring it is leveled and the laser bisects the new line made which represents the “actual 
ROI”. 









   
Figure 2:Representation of preparation for confirmation CBCT 
A. Displaying the XYZ plane relevance to tibia sample. B. Interpretation of Rotation on the CBCT 
Software (InVivo6). C & D. Rotation device to translate rotation data to sample in falcon tube 
and the red line representing the “actual ROI” alignment site. 
 
After successfully assessing the alignment with the confirmation CBCT, a needle 
confirmation CBCT was taken to re-confirm the alignment and confirm the area of the ROI 
within the reference needles (15 -25mm area). This 15-25 mm area will be measured on the 
InVivo 6 software and translated to the tube as two reference points which will be the 
sagittal cut measurements, placed along the confirmed line (“Actual ROI”). A similar line 
will be made on the lateral aspect that is 90° to the confirmed line with the measurements 
for coronal cut measurements, which the ROI is within an 8 mm region or a sagittal cut 
measurement, where the ROI is within 15-25 mm distance that will include the head of 
tibia. We stabilize the falcon tube on a clamp and use a laser to align with the confirmed 
line, we will puncture the two reference points and insert a B-D 22-gauge 1-inch(22G1) 
needles (PrecisionGlide®) perpendicular to the tibia and the laser bisects the needles 








needles in position with flowable resin (fig 3B) and cure it (fig 3C). After the needles are 
placed properly a needle CBCT is taken in the same manner of the primary and 




Figure 3: Representation of preparation for Needle CBCT 
A. Shows the alignment of the needles on the confirmation line and the laser bisecting. B. Use of 
flowable resin to secure and seal the needles in position on falcon tube. C. Curing of flowable 
resin. D. Position of sample with needles in iCAT CBCT machine. 
A B 








After the confirmation of the alignment of the needles with the ROI on the InVivo6 
software, the sample will be prepared for a final tattoo CBCT. The falcon tube will be 
punctured at the two points (coronal cut or sagittal cut) along the 90° reference line (fig. 
4A) and two needles will be placed. A 1 ml insulin syringe with a 22G1 needle was filled 
with 1% Evan Blue solution (~0.1 g of Evans Blue dissolved in 10 mL PBS). The needles are 
removed from the falcon tube that is in alignment of the ROI, afterwards the needle and 
syringe that contains the Evan’s blue solution is inserted on the tibia where the previous 
needles were, to mark the reference measurements and alignment (fig. 4B). The same is 
done on the 90° reference marks as well.  The tattooed tibia sample is transferred into a 
new falcon tube with fresh 10% buffered formalin (fig. 4C). After the samples are prepared 
with the tattoos, a tattoo confirmational CBCT will be taken to confirm the alignment. The 
tibia in the falcon tube is placed in the holder, same as the other CBCT assessments (making 
sure the base is leveled) and the laser should bisect both reference tattoos to check the 
alignment (fig. 4D). We will do the final review of the tattoo CBCT on the InVivo6 software, 
once successfully confirm the correct alignment of the location of the ROI, the samples will 







    
Figure 4:Representation of preparation for Tattoo CBCT 
 A. Representation of needles placed along 90° reference and the anterior alignment reference line. 
B. placement of 1 mL syringe with Evan’s Blue solution on the reference marks once needle is 
removed. C. Prepared tattooed tibia sample in new falcon tube with 10% buffered formalin. D. 




Figure 5: Representation of the series of CBCT analysis with InVivo6 software to determine ROI 
A. Image of primary CBCT to identify the ROI on software after the necessary rotation. B. Image 
displaying the sagittal cut reference points made for the tentative needle location C. Image of 
conformation CBCT confirming the new reference alignment line. D. Image of the needle CBCT 
of the two needles confirming the alignment of the ROI. E. Image of the tattoo CBCT when the 
laser aligns with the tattoo reference marks to confirm the location of ROI. 
 
 





Histological sample preparation and processing. 
➢ Decalcification Protocol: 
The tibia samples must be decalcified before processing it for histological sectioning.  
Samples were decalcified with pH 7.1 -14% w/v EDTA (Ethylenediaminetetraacetic acid) Buffer 
solution. Two liters was prepared; 280 g EDTA (Sigma®) powder was dissolved in 1.5 L of 
distilled water and 180 ml ammonium hydroxide (Fisher®) and the pH was adjusted to ~ 7.1. 
The 10% formalin was replaced with the EDTA decalcification buffer, the tibia samples in a 50 
ml falcon tubes were placed on a shaker in 4 °C. The decalcification buffer was changed every 
week with fresh buffer for 4 to 6 weeks. On week 3 the tibia was cut on sagittal cut tattoo 
reference point to expose the bone underlying the muscle. After 4 to 6 weeks, the decalcified 
sample required a second cut for processing and embedding. Two tibia samples were prepared for 
coronal (axial) sectioning (~ 8 mm) (Fig 6 a-c) and one was prepared for sagittal sectioning (15-
25 mm) (fig 6 e &f). In the coronal (axial) sections second cut, the excess muscle and bone was 
trimmed (margin will be 2 mm from the ROI) so it will fit the cassette. In the sagittal section 
excess tissue from the bottom and top was trimmed, the length was 15-25 mm and sagittal 
trimming was cut ~ 1 mm away from the ROI and the section will be approximately 2-2.5 mm in 
thickness. Each cassette was labelled according to the sample number, surgical group and day. 
The ROI portion was faced down in the cassette (fig 6 d & g) and placed in 70% ethanol in 4°C. 







    
   
Figure 6:Representation of trimming of tibia samples for histology 
a. Tibia specimen with 90° tattoo showing guide for coronal cut guide b. the coronal cut of 
specimen showing the thickness of 8-10 mm c. The ROI aspect of the tibia that will be faced down 
during embedding. d. Coronal(axial) cut sections placement in the cassette. e. Tibia specimen 
with sagittal cut tattoo on anterior aspect of specimen. f. Sagittal cut specimen showing the ROI, 
which will be faced down during embedding and the length 15-25 mm. g. Sagittal cut section 
placement in the cassette. 
 
 
➢ Specimen processing and embedding: 
The specimens were trimmed and placed in cassettes in 70% ethanol. The tibia sample were 
dehydrated with 85% ethanol for 4 hours, 90% ethanol for 2 hours and 10 mins, 95% ethanol for 
1 hour and 40 mins, 100% ethanol bath I for 1 hour and 40 mins, 100% ethanol bath II for 35 
mins, 100% ethanol mixed with xylene mix (1:1 ratio) for 40 mins, followed by a xylene bath I 
for 10 mins and then xylene bath II for 10 mins. The cassette was transferred to a paraffin bath 













For embedding, the tibia specimen was transferred to a metal boat with the side of the ROI 
facing the boat. The paraffin was heated to 65° C and dripped onto the tibia specimen until it is 
fully covered. The cassette was placed on the top of the waxed specimen and additional wax was 
dripped till the mesh is covered in wax as well, to ensure the cassette is securely placed. The 
specimen imbedded in wax is then cooled and formed into a block. Caution should be taken not 
to have bubbles in the paraffin block, as it can cause difficulty in cutting sections. 
 
➢ Sectioning & preparation of slides. 
After the embedded specimen blocks were received, the tibia specimens were sectioned in-
house. The blocks were first trimmed [ENCORE PTFE-coated low profile- microtome blade] on 
the microtome [Leica- RM2255] at the setting of 10µm till the tissue was reached then, sectioned 
at 6µm thickness with the blade positioned at 5° angle. Once the ROI was reached, 5 rows of 
ribbons 18 slices long were transferred 2 sections at a time to the water bath (37°C) and the 
sections were scooped on to the slide [Fisherbrand- Superfrost plus microscope slides]. The slides 
were labelled with the specimen number, day of harvest, and section number (sequential slides 
were prepared). Twelve slides (2 sections per group) were placed in the 37°C incubator 








Figure 7: Microtome 










➢ H & E (Hematoxylin and Eosin) Staining Protocol 
H & E staining is one of the principal methods used for histological analysis. It is a 
combination of two histological stains: hematoxylin and eosin. Hematoxylin stains the cells 
nuclei, keratohyalin or calcified tissues blue (or dark purple) and the eosin stains the extracellular 
matrix, collagen, cytoplasm, and other tissues (uncalcified) pink. The stain allows us to see the 
overall distribution of cells and the cell types present in the specimen. The slides need to be de-
paraffinized and re-hydrated prior to staining. 
 Steps of de-paraffinization of slides:  
1) 10 mins in xylene (2 times) 
2) 10 mins in 100% ethanol 
3) 10 mins in 95% ethanol 
4) 5 mins in 90% ethanol 
5) 5 mins in 70% ethanol 
6) 5 mins in PBS (phosphate buffered saline). 
 
➢ H&E Staining:  
First the slides were submersed in hematoxylin solution (Fisher HealthCare) for 5 minutes, 
rinsed in continuous tap water for 10 minutes, dipped 5 times in Eosin solution (Sigma-Aldrich), 
then 10 seconds in 70% ethanol, 10 seconds in 90% ethanol, 10 seconds in 95% ethanol, 2 to 3 
minutes in 100% ethanol, 2 minutes in xylene (2 times), finally Cytoseal 60 and cover with cover 
slip were added [Fisherfinest® Premium Cover Glass (22x50, 0.13-0.17mm thickness). The 






➢ TRAP Staining 
Tartrate Resistant Acid Phosphatase staining is used to define osteoclast activity during in 
bone resorption. Osteoclasts resorb mineralized bone matrix and calcified tissues. They have a 
unique morphologic phenotypic characteristic that identifies them, such as multinuclearity and 
expression of TRAP (tartrate-resistant acid phosphatase) that can be a biomarker for bone 
resorption. 
➢ Solutions in TRAP Staining: 
1) TRAP Basic Incubation Medium: Sodium Acetate Anhydrous [Sigma]- 9.2 g, L-(+) 
Tartaric Acid [Sigma]-11.4 g, Distilled water – 950 mL, Glacial and Acetic Acid- 2.8mL, 
is dissolved and pH is adjusted to 4.7 -5.0 with 5M Sodium hydroxide to increase or 
distilled water to decrease pH and bring total volume to 1 L. 
2) Naphthol AS-MX Phosphate Substrate mix: Naphthol AS-MX Phosphate [Sigma](stored 
at - 20°C)- 20 mg and Ethylene Glycol Monoethyl Ether [Sigma]– 1 mL is placed in 2 mL 
Eppendorf tube and vortexed till dissolved. 
3) TRAP Staining solution mix (made fresh each time): TRAP Basic Incubation Medium- 
200mL, Fast Red Violet LB Salt [Sigma]- 120 mL and Naphthol AS-MX Phosphate 
substrate mix – 1 mL 
4) 0.02% Fast Green: Fast Green – 0.05g and distilled water – 250 mL 
5)  
➢ Staining Protocol for TRAP: 






2. De-paraffinize slides and rehydrate through graded ethanol (100%, 95%,90% and 
70%) to distilled water. 
3. Place slides in pre-warmed TRAP staining solution Mix and incubated at 37°C for 30 
mins or until control is developed. 
4. Counterstain with 0.02% Fast Green for 30 secs and rinse quickly in distilled water. 
5. Dehydrate quickly through graded ethanol (70%, 90%, 95% and 100%), 5 seconds 
each, clear in Xylene and mount coverslip. 
The osteoclasts that are positive will stain red violet and the background will be green, a negative 
control slide will be stained for comparison. 
➢ Masson’s Trichrome Staining 
Mason’s trichrome- is a three-color staining protocol to distinguish cells from surrounding 
connective tissue. (Red – keratin and muscle fibers. Blue or green-collagen and bone. Light 
red or pink- cytoplasm. Dark brown to black- cell nuclei) trichrome solution consists of 3 
different solutions labelled as A, B and C: 
• Solution A (plasma stain): contains acid fuchsin, xylidine ponceau, glacial acetic acid and 
distilled water. 
• Solution B: contains phosphomolybdic acid in distilled water. 
• Solution C (fiber stain): contains light green SF yellowish or Fast green FCF (used to 
stain collagen). If blue is preferred to green, methyl blue or water blue can be substituted. 
The staining is be used to identify changes in collagen structures (new collagen deposition or 
bone formation). Reticular fibers are composed of type III collagen secreted by reticular cells 






➢ Masson’s Trichrome Protocol [SIGMA-ALDRICH®] 
➢ Reagents: 
1. Biebrich Scarlet-acid Fuchsin Solution- 250 mL (catalog no. HT151): Biebrich scarlet 
0.9%, acid fuchsin 0.1%, in acetic acid 1.0%. 
2. Phosphotungstic Acid Solution- 250 mL (catalog no. HT152): Phosphotungstic acid 
10%. 
3. Phosphomolybdic Acid Solution- 250 mL (catalog no. HT153): Phosphomolybdic 
acid 10%. 
4. Aniline Blue Solution- 250 mL (catalog no. HT154): Aniline blue 2.4% and Acetic 
acid 2%. 
➢ Procedure: 
The slides must be deparaffinized and hydrated in graded alcohol (100%, 95%, 90% and 70%) to 
deionized water. The slides were placed in Bouin’s solution [SIGMA](37-40% Formaldehyde, 
saturated Picric acid and glacial acetic acid) was preheated for 15 minutes to 56°C. The slides 
were cooled under tap water (18-26°C), Then stained in Weigert’s iron hematoxylin for 5 
minutes, then washed under running tap water for 5 minutes and rinsed in deionized water after. 
Slides were then stained with Bierich Scarlet-Fuchsin for 5 minutes and then rinsed deionized 
water. The slides were then placed in working Phosphotungstic/Phosphomolybdic Acid solution 
for 5 minutes, Aniline Blue solution for 5 mins and placed in 1% Acetic acid for 2 minutes. The 
slides were then rinsed in tap water and dehydrated in graded Ethanol (70%, 90%, 95% and 














Figure 8: Graphical representation of Primary CBCT to determine the ROI 
 The negative values represent rotation to the Left and positive values is to Right and Zero 









Figure 9: Graphical representation of Secondary CBCT to determine the ROI 
The negative values represent rotation to the Left and positive values is to Right and Zero 
representing the correct region with no rotation. CBCT2 showing the accuracy related to CBCT 






Figure 10: Statistical analysis of the frequency of rotation comparing CBCT1 to CBCT2 
(IBM SPSS Statistics 27- Statistical Software)
 
The CBCT1 is the representative of variance from the manually un-assisted initial 
reference before CBCT analysis, where 0.00 represents the accuracy of no additional rotation to 
locate the ROI, and any number other than 0.00 shows a deviation from the "assumed" site to the 
relative location of the ROI. CBCT2 represent the accuracy-related to the use of digitally guided 
image analysis via CBCT, to determine the ROI's location. Five samples needed an additional 







➢ Histological and Immunohistochemistry Findings 




Figure 11: Histological H&E staining representation of tibia at 4X Magnification for Day 1. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group.  
















Figure 12: Histological H&E staining representation of crest of tibia at 4X Magnification for Day 1. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group.  
























Figure 13: Histological H&E staining representation ROI of tibia at 10X Magnification for Day 1. 
A. Piezo Deep group. Arrow showing the vessel size and content population. B. Bur Deep Group. 
Arrow showing the vessel size and content population C. Piezo Shallow Group. D. Bur Shallow 
Group. E. Sham Group and F. Control Group. 
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Figure 14: Histological H&E staining representation of marrow side of tibia at 10X Magnification for 
Day 1. 
A. Piezo Deep group. B. Bur Deep Group. Arrow showing the bone particulate which was pushed 



















Figure 15: Histological H&E staining representation of periosteal side of tibia at 10X Magnification 
for Day 1. 
A. Piezo Deep group. B. Bur Deep Group C. Piezo Shallow Group. D. Bur Shallow Group. 
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When reviewing the H&E staining for the Day 1, it was noted that in the piezo deep (PD) 
group there was no notable increase in vessel size and minimal presence of leukocytes and only 
the presence of RBCs. The fibrin formation was noted with the populated with RBCs. Also, there 
was a vast disruption of the bone matrix, the osteocytes were haphazardly arranged which lacked 
the concentric arrangement around the haversian system and osteocytes lacked a connection to 
one another with shrinkage of the nuclei or missing nuclei. In the PD group, there were a few 
plasma cells and inflammatory cells present. In the marrow space, no bone particulate was found 
from the surgery and there was a presence of RBCs and megakaryocytes. For the bur deep (BD) 
group there was notable enlargement of the vessels in the bone with a large presence of 
leukocytes and the normal RBCs. The fibrin formation was noted with the presence of RBCs. 
The bone matrix was mildly disrupted, and the osteocytes remained connected and were arranged 
concentrically around the haversian system. In the marrow space of the BD group remnants of 
large bone particulate from the surgery was seen, with presence of more multinucleated cells 
(megakaryocytes) and RBCs. In the piezo shallow (PS) group, there was no increase in vessel 
size and the fibrin clot was noted on the periosteal side populated with RBCs. Disruption of the 
bone matrix was noted with haphazard arrangement of the osteocytes, lacking the concentric 
arrangement around the haversian system and shrinkage of the nuclei of the osteocytes. The 
marrow space had the presence of a few multinucleated megakaryocytes and RBCs. For the bur 
shallow (BS) group, a slight enlargement of blood vessel size was noted, with presence of PMNs 
in the vessels adjacent to the lesion. Fibrin formation was seen on the periosteal side populated 
with RBCs. The osteocytes were arranged concentrically around the haversian system and the 
nuclei size remained unaffected. In the marrow space of the bur shallow group there was 
presence of few megakaryocytes and normal population or RBCs. For the sham group the 





periosteum appeared enlarged with the presence of PMNs. The osteocytes nuclei remained 
unaffected and were arranged concentrically around the haversian system. The marrow space was 
populated with RBCs and a few megakaryocytes. The control group was used as a comparison 
for the size of the vessels, the integrity of the bone, arrangement of the osteocytes, intact 
periosteum, and the normal content of the marrow space. In the sham, PD, BD, PS and BS groups 














































Figure 16: Histological H&E staining representation of tibia at 4X Magnification for Day 3. 
A. Piezo Deep group. Arrow showing the new bone formation. B. Bur Deep Group. Arrow 
showing the remnant bone particulate in marrow space. C. Piezo Shallow Group. D. Bur Shallow 
Group. E. Sham Group. Arrow showing the thickening of periosteal surface.  F. Control Group. 
Marrow 
Side 









Figure 17: Histological H&E staining representation of crest of tibia at 4X Magnification Day 3 
A. Piezo Deep group. The Arrow showing the aggregation of cells. B. Bur Deep Group. C. Piezo 
Shallow Group. D. Bur Shallow Group. E. Sham Group. The arrow is showing the aggregation of 
cells. F. Control Group 
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Figure 18: Histological H&E staining representation ROI of tibia at 10X Magnification for Day 3. 
A. Piezo Deep group. Arrow showing the new bone formation. B. Bur Deep Group. Top arrow 
showing new bone formation and bottom arrow showing the remnant bone particulate. C. Piezo 
Shallow Group. Arrow showing new bone formation. D. Bur Shallow Group. Arrow showing new 
bone formation. E. Sham Group. Arrow showing a collagenous sort of milieu. F. Control Group. 
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Figure 19: Histological H&E staining representation of marrow side of tibia at 10X Magnification for 
Day 3. 
A. Piezo Deep group. Arrow showing the new bone formation. B. Bur Deep Group. Both arrows 
showing the remnant bone particulate. C. Piezo Shallow Group. Arrow showing new bone 



















Figure 20: Histological H&E staining representation of periosteal side of tibia at 10X 
Magnification for Day 3. 
A. Piezo Deep group. Arrow showing the new bone formation. B. Bur Deep Group. Both arrows 
showing new bone formation. C. Piezo Shallow Group. Arrow showing new bone formation. D. 
Bur Shallow Group. Arrow showing new bone formation. E. Sham Group. Arrow showing 
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When reviewing the Day 3 H &E staining, we noted that in the PD group the vessels 
remained normal size and no evidence of inflammatory cells. The bone adjacent to the lesion still 
looked slightly disrupted and the osteocytes were haphazardly arranged, and osteocytes lacked 
nuclei. The periosteum showed evidence of increased activity with a new bone formation and in 
the marrow spaces, there was activity of the bone marrow cells with a collagenous milieu 
substance. The fibrin clot was present in the lesion with less RBCs and fibroblasts. In the BD 
group the vessels in the bone had returned to normal size and no evidence of leukocytes in the 
vessels. Bone adjacent to the lesion seemed unaffected, the osteocytes remained connected and 
were arranged concentrically around the haversian system. The periosteal side was showing more 
evidence of activity and healing with bone formation in comparison to the marrow side. The 
marrow space had the remnant of the bone particulate from the surgery and showed more 
megakaryocyte population in comparison to PD. The fibrin clot has a presence of a few RBCs 
and fibroblast when compared to the Day 1 BD group. In the PS group the fibrin network was 
still present with RBCs and fibroblastic cells. The vessels remained normal size with no sign of 
PMN or inflammatory cells. The bone matrix adjacent to the lesion had a haphazard arrangement 
of the osteocytes which a few were lacking nuclei. The periosteum appeared bulkier and evidence 
of new bone formation. The marrow side showed a small area that looked activated with the 
presence of a collagenous milieu substance. In the BS group the vessel size looked normal with 
no presence of inflammatory cells. The periosteum was not thickened, and the marrow space did 
not look affected. The osteocytes were arranged concentrically around the haversian system. The 
sham group the vessel size was normal, with no presence of inflammatory cells. The marrow 
space did not look affected, normal content of RBCs and few megakaryocytes. The osteocytes in 
the bone matrix were arranged in a concentric manner around the haversian system. The 





In the PD, BD. PS, BS, and sham group there was an increase of population of chondrocytes at 
the crest of the tibia. The control group was used as a comparison of normality of bone matrix, 































Day 7 – H&E staining analysis 
 
 
Figure 21: Histological H&E staining representation of tibia at 4X Magnification for Day 7. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. 
E. Sham Group. Arrow showing chondrocytes in the thickened periosteal surface.  F. Control 
Group. 
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Figure 22:Histological H&E staining representation of marrow space of tibia at 4X 
Magnification for Day 7. 
A. Piezo Deep group. B. Bur Deep Group. Arrow showing remnant bone from surgery in marrow 











Figure 23: Histological H&E staining representation of crest of tibia at 4X Magnification for 
Day 7. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 
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Figure 24:Histological H&E staining representation periosteal surface of tibia at 10X 
Magnification for Day 7 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 
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Figure 25: Histological H&E staining representation ROI of tibia at 10X Magnification for 
Day 7. 
A. Piezo Deep group. Arrow is showing the collagen being laid down replacing fibrin network in 
the ROI. B. Bur Deep Group. Arrow is showing the presence of the fibrin network between the 
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Figure 26: Histological H&E staining representation marrow space of tibia at 10X 
Magnification for Day 7. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 

















When reviewing the Day 7 H&E staining, the PD group’s periosteal surface surrounding 
the tibia appeared bulkier and activated with a sort of callus/bone formation. The callus present in 
the surgical defect extended 1/3rd into the marrow space, a more organized and close-knit 
arrangement replacing the fibrin network with a small population of fibroblast and RBCs. Also, 
evidence of osteoblasts around the callus, with the presence of a few osteoclasts. The osteocytes 
in the bone matrix were returning to a concentric arrangement around the haversian system 
adjacent to the ROI, with absence of many nuclei. The blood vessels appeared normal size and 
marrow space content as well. At the crest of the tibia there was a very large population of 
chondrocytes, which appeared hypertrophic and presence of being differentiated.  The BD 
group’s  periosteal surface was not as pronounced as the PD group, the thickening was present 
around ~ ½ of the circumference of the tibia. The callus in the defect was very prominent and 
spaced out with portions of the fibrin network present and extending into the whole marrow 
space. The remnants of bone from the surgery had new bone forming around it. Higher 
population of fibroblasts in the fibrin and presence of osteoblasts with a few osteoclasts in the 
callus. The osteocytes in the bone matrix were arranged concentrically around the haversian 
system and absence of nuclei in osteocytes immediately adjacent to the ROI and in the remnant 
islands of bone in the marrow space. Drastically increased population of hypertrophic 
chondrocytes at the crest of the tibia, with a much larger cell appearance in the BD group 
compared to the PD group. Blood vessels remained normal and marrow space was difficult to 
discern due to presence of callus. Around 2/3rd  of the PS group’s periosteal surface around the 
circumference of the tibia was thicker with a callus-like formation or activated bone.  There was 
absence of callus formation in the defect area,  with a presence of a fibrin network, which was 
heavily populated with fibroblasts. The osteocytes in the bone matrix appeared arranged slightly 





with some absence of nuclei. There was presence of hypertrophic chondrocytes at the crest of the 
tibia as well. In the BS group’s periosteal surface, slightly more than 1/3rd the circumference of 
the tibia is thickened with the callus-like or activated bone formation. There was no evidence of 
callus formation in the defect area, only the presence of fibrin network which is heavily 
populated with fibroblasts and a few RBCs. The osteocytes in the bone matrix adjacent to the 
ROI were arranged in a concentric manner around the haversian system, and the nuclei were 
present. The blood vessels appeared normal, and the marrow space was unaffected. The crest of 
the tibia showed chondrocyte activity, but no hypertrophic chondrocytes were present. In the 
sham group approximately 1/3rd of the periosteum around the circumference of the tibia was 
thickened with a callus-like or new bone formation activity. There was very large population of 
hypertrophic chondrocytes present at the periosteal surface, where the full thickness flap was 
reflected. The osteocytes in the bone matrix were arranged in a concentric manner around the 
haversian system and the nuclei were present. The blood vessels appeared normal and the marrow 
space as well. The chondrocytes were heavily populated at the crest of tibia, which appeared 
enlarged and hypertrophic. The control group was used as a comparison of normality of bone 



























Figure 27: Masson’s Trichrome staining representation of tibia at 4X Magnification for Day 1. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 










Figure 28: Masson’s Trichrome staining representation of the crest of tibia at 4X 
Magnification for Day 1. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 











Figure 29: Masson’s Trichrome staining representation of marrow space of tibia at 4X 
Magnification for Day 1 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 






 When reviewing the Day 1 Masson’s Trichrome staining all the groups (PD, 
BD, PS, BS, Sham and Control) showed predominantly blue (bone or collagen containing) 
throughout the tibia,  with a slight red mix in the BD group only .  The marrow spaces 
stained a purple color along with the fibrin network in the lesion. The muscles surrounding 
the tibia had stained red. The control group was used to determine the difference of 




























Figure 30: Masson’s Trichrome staining representation of tibia at 4X Magnification for Day 3. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 








Figure 31: Masson’s Trichrome staining representation of the crest of tibia at 4X 
Magnification for Day 3. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 











Figure 32: Masson’s Trichrome staining representation of marrow space of tibia at 4X 
Magnification for Day 3 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 







When reviewing the Day 3 Masson’s Trichrome staining all the groups (PD, BD, PS, 
BS, Sham and Control) showed predominantly blue (bone or collagen containing) 
throughout the tibia,  with a slight red mix in the BD group only .  At the crest of the tibia the 
bone stained blue, and the aggregation of the cells seen in PD, PS, BS and Sham group 
stained purple. The marrow spaces stained a purple color along with the fibrin network in 
the lesion. In the marrow space of the BD group , the remnant bone particulate stained blue. 
The muscles surrounding the tibia had stained red in all groups. The control group was 


























Figure 33: Masson’s Trichrome staining representation of tibia at 4X Magnification for Day 7. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 









Figure 34:Masson’s Trichrome staining representation crest of tibia at 4X Magnification for 
Day 7. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 










Figure 35:Masson’s Trichrome staining representation marrow space of tibia at 4X 
Magnification for Day 7. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 






When we reviewed the Masson’s Trichrome staining for the Day 7 Tibia groups, there 
was predominantly blue ( bone/collagen- containing material) throughout all the groups (PD, BD, 
PS, BS, Sham and Control). At the crest of the tibia there was blue stain in all experimental 
groups. Around the circumference of the tibia where the reactive callus formation present in PD, 
BD, PS, BS and Sham stained blue as well. The muscles surrounding the tibia had stained red 
in all groups.  The control group was used as a comparison of the “normal” osteoclast population 



























Figure 36: TRAP staining representation of periosteal side of tibia at 10X Magnification for 
Day 1. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 









Figure 37: TRAP staining representation of ROI of tibia at 10X Magnification for Day 1. 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 










Figure 38:TRAP staining representation of marrow space of tibia at 10X Magnification for 
Day 1 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 








Figure 39: TRAP staining representation of crest of tibia at 10X Magnification for Day 1 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 






When we reviewed the TRAP staining analysis for the Day 1 PD, BD, PS, BS, Sham and 
Control groups, the TRAP staining was negative. Therefore, there was no evidence of osteoclasts 
in the Day 1 investigating groups. The control group was used as a comparison of the “normal” 


















Figure 40 :TRAP staining representation of periosteal side of tibia at 10X Magnification for 
Day 3 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo deep group periosteum side immediately 
above ROI. D. Bur deep group periosteal side immediately above ROI. E. Piezo Shallow Group. 





















Figure 41: TRAP staining representation of ROI of tibia at 10X Magnification for Day 3. 
A. Piezo Deep group. B. Bur Deep Group. Piezo Shallow Group. D. Bur Shallow Group. E. Sham 











Figure 42: TRAP staining representation FAR from ROI of tibia at 10X Magnification for Day 
3. 
The Arrows are showing the presence of osteoclasts. A. Piezo Deep group. B. Bur Deep Group. 















Figure 43: TRAP staining representation of marrow space of tibia at 10X Magnification for 
Day 3 
A. Piezo Deep group. B. Bur Deep Group. C. Piezo Shallow Group. D. Bur Shallow Group. E. 








Figure 44: TRAP staining representation of crest of tibia at 10X Magnification for Day 3 
A. Piezo Deep group. Arrows showing the appearance of developing osteoclasts.  B. Bur Deep 
Group. Arrows showing the appearance of developing osteoclasts. C. Piezo Shallow Group. 
Arrows showing the appearance of developing osteoclasts. D. Bur Shallow Group. E. Sham. 
Group. Arrows showing the appearance of developing osteoclasts. F. Control Group. Arrows 





When we review the Day 3 TRAP stained positive for some of the experimental 
groups, which had shown the appearance of developing osteoclasts was noted. In the PD 
and BD groups, a few developing osteoclasts were seen at the crest of tibia and regions far 
from the ROI, more were seen in the PD group.  In the PS, Sham, and control groups few 
developing osteoclasts were seen at the crest of tibia as well. There was a moderate 
population of osteoclasts on the back side of the tibia of the control group. The control 



























Figure 45: TRAP staining representation of periosteal side of tibia at 10X Magnification for 
Day 7 
* Arrows representing the presence of osteoclasts .A. Piezo Deep group. B. Bur Deep Group.  









Figure 46: TRAP staining representation of ROI of tibia at 10X Magnification for Day 7. 
*Arrows representing the presence of osteoclasts. A. Piezo Deep group. B. Bur Deep Group. 













Figure 47:TRAP staining representation of marrow space of tibia at 10X Magnification for 
Day 7 
*Arrows representing the presence of osteoclasts. A. Piezo Deep group. B. Bur Deep Group.  












Figure 48 :TRAP staining representation of crest of tibia at 10X Magnification for Day 7. 
*Arrows representing the presence of osteoclasts. A. Piezo Deep group. B. Bur Deep Group.  






 When reviewing the TRAP Staining for Day 7, all the experimental groups showed 
presence of osteoclasts.  The PD group showed a greater population of osteoclasts in the 
ROI and marrow space of the reactive callus in comparison to BD, PS, BS, and sham groups. 
The PS and sham group had shown a larger population of osteoclasts at the crest of tibia in 
comparison to PD, BD, and BS.  The control group was used as a comparison of the “normal” 








➢ CBCT Analysis to Localize ROI 
The initial incision through the skin did not align with the penetration wound on the tibia, 
therefore it was necessary to accurately locate the tibial wound before tissue sectioning and 
staining. We used CBCT to accurately locate the region of interest (ROI). It was necessary to 
position the tibias for CBCT. This was accomplished by rotation and tattooing the tibia on its 
finalized location.  When the CBCT scans used to localize the ROI were reviewed and compared 
to a conventional unassisted approach, the CBCT method was 98.2 % accurate, while the un-
assisted approach was 1.8 % accurate. Human error in translating the angle of rotation precisely 
on to the falcon tube, was the reason behind the failure of the 5 failed samples. If the falcon tube 
was not completely level, we were required to re-assess those samples. Correction of human error 
was very simple and easily done and resulted in 100% accurate localization of the ROI. When we 
prepared the samples for histological processing, the cut along the sagittal tattoo line on the 
anterior aspect bisected the ROI. Localization of the ROI with the CBCT allowed us to prepare 





distance of the margin of tissue necessary to cut reach the ROI with the aid of the CBCT image 
taken, this defeated the blind approach of histology sectioning of a highly specific ROI and gave 
a clear understanding the proximity and appearance of the lesion. 
The specimens were processed for both axial and sagittal sectioning due to difficulty in 
sagittal sectioning of the large tibia, we found sectioning the specimen in the axial direction more 
manageable. The axial direction also allowed us to see a clearer view of the Haversian system 
and the arrangement of the bone matrix. The steps needed to localize the ROI, has given us the 
confidence to prepare the specimens for histological study. 
 
➢ Histological and Immunohistochemistry Analysis 
The results of this experiment showed different reactions in the overlying tissues and bone 
healing in the PD, BD, PS, BS, and Sham groups. The PS and BS groups had a less intense 
healing response compared to the PD and BD treatment groups. This agrees with outcomes 
previously reported  for the PD groups represented by Kernitsky et al [9].  
On Day 1, a controlled inflammatory response occurred in the PS and PD groups with an 
inflammatory infiltrate, fibroblasts, RBCs and with limited population of PMNs were present in 
the fibrin clot at the lesion and minimal disruption of vessels adjacent to the ROI, in the BD,BS 
and Sham groups. An acute inflammatory response occurred with enlargement of blood vessels 
with a greater population of inflammatory infiltrate (PMNs) in the vessels adjacent to the ROI. 
The fibrin clot in the BD and BS groups contained more fibroblasts and PMNs compared to the 
PD and PS groups. Optimal wound healing necessitates an inflammatory response [49] from the 
injury and structural damage which was inflicted [13]. Disruption of the bone matrix was noted in 
the piezo groups (PD and PS), which a haphazard arrangement, but not decreased numbers of 





piezoelectric knife [1] disrupted but did not necessarily damage the osteocytes. This oscillatory 
vibration may also have caused increased pressure in the lacunocanalicular processes [17] [50] 
leading to a larger population of osteocytes being affected and initial shrinkage of the osteocyte 
nuclei on Day 1. Masson’s trichrome stains bone and predominantly collagen-containing tissue 
blue. The Day 1 showed predominantly blue staining of the tibia, the marrow stained purple 
along with the clot present in the lesion. This confirmed that the marrow and lesion did not 
contain any bone or collagen-containing tissues. There was no osteoclastic activity in any of the 
Day 1 samples, was indicated by negative TRAP staining. 
On Day 3, the osteocytes in the bone matrix adjacent to the ROI were still haphazardly 
arranged. More nuclei were missing in the osteocytes. Since the osteocytes are considered the 
“mechano-sensors” of bone [51], this disarrangement of osteocytes cause apoptosis, where the 
nuclei shrink [18] [17], the piezo groups affect a larger surface area of the bone matrix which was 
also observed by Reside et al. [52]. The activation of a RAP was more pronounced compared to 
the bur groups (BD and BS). The disruption of the bone matrix on the external surface of the bur, 
was milder and limited compared to the piezo groups. Optimal generation of a streaming 
potential could accelerate bone remodeling in the canalicular processes in the Haversian canals 
[17] which could be a feasible explanation for the increased activation response of the piezo 
groups. As more osteocytes undergo apoptosis there will be decreased in expression of TGF-β 
which will promote osteoclast stimulating factors [18]. The periosteum has its own population of 
MSCs [25] that play a role in bone healing. The periosteal MSCs gives rise to chondrocytes 
which ultimately laydown new bone matrix [25] [29]. The Day 3 histological sections from the 
PD group, the periosteal surface around the circumference of the tibia was dramatically 
thickened. A lesser degree of thickening was noted in the BD, PS, BS, and Sham groups. This 





population of the periosteum [53]. The increased  population of chondrocytes at the crest of the 
tibia in the PD, BD, PS, BS, and sham groups was suggestive of increased activation of bone 
remodeling. The PD showed the greatest increase in chondrocytes at the crest of the tibia. On the 
marrow side the PD group showed increased activation of cells within the marrow space, with a 
collagenous matrix and new bone formation at the endosteal side. The BD treatment group also 
showed activation within marrow space with the remnant bone present, with greater number of 
fibroblastic cells but it was less than the PD group. The PS and BS groups showed no activity in 
the marrow space suggesting that the marrow cells were not stimulated. The fibrin network in the 
PS and BS groups were populated with RBCs and fibroblasts, but the PS groups had fewer 
fibroblastic cells indicative of a more controlled inflammatory response. The PD group had a 
more organized fibrin network with a smaller population of fibroblastic cells compared to the BD 
group. There was some new bone formation on the periosteal side adjacent to the ROI in the PD 
and BD group, but there was more in the PD group, suggesting higher bone turnover. The 
Masson’s trichrome showed predominant blue stain throughout the bone matrix, where the 
thickening of the periosteal side and crest of tibia showed mixed blue and purple staining in PD, 
PS, and BS groups. This is indicative of the presence of collagen in the thickening of the 
periosteal tissues, which can lead to new bone formation. The marrow space and lesion in PD, 
BD, PS and BS groups stained purple in with the Masson’s trichrome staining, confirms the lack 
of collagen-containing tissues in these areas. The Day 3, PD, BD and PS had positive TRAP 
staining, showing the appearance of developing osteoclasts. BS, Sham and Control groups were 
TRAP negative. Previous studies by Ohira et al. [18]  also showed osteoclastic activity at Day 3 
in the piezoelectric surgery groups. Other studies by Horton et al. [6] had mentioned the minimal 
numbers of osteoclasts following Day 3 rotary bur surgery. Osteoclastic activity is initiated by 





undergoing apoptosis in the Piezo groups will increase the expression of RANKL and suppress 
the OPG levels [13] [19], which will differentiate the osteoclasts more rapidly.  
The Day 7 periosteal thickening around the circumference of the tibia resulted in a large 
callus-like or an intramembranous woven bone formation [55]. This vascularized cartilage callus 
indicates rapid turnover of cartilage with increased remodeling of bone and a thicker cortical 
shell [53] which was most prominent in the PD and sham groups. Previous studies by Kernitsky 
et al. [9] showed similar results in the piezo deep penetration groups as well, indicating a greater 
activation of the periosteal MSCs. Yaffe et al. [56] had indicated that a full thickness periosteal 
flap was sufficient to initiate the phenomenon of RAP, whereas when it is combined with a 
surgical intervention it would likely create a greater RAP effect overall [54]. The callus in the 
ROI of the PD group was more linearly organized pattern and closely arranged when compared to 
the callus of the BD group, which was loosely and haphazardly arranged. Also, the callus of the 
BD group still had spaces of fibrin mesh network with a population of fibroblasts, and RBCs. 
This is indicative of a slower bone remodeling timeline in comparison to PD. The reactive callus 
was found throughout the marrow space of the BD group, which could be suggestive of a 
reaction from the remnant bone particulate from the surgery. The presence of osteoblasts between 
the callus network were noted in the PD and BD groups, indicating of new bone formation and 
bone remodeling process [57]. The presence of a more tightly knit and dense bone can provide 
more stability, which may be favorable for future implant placement [58]. The crest of the tibia 
showed activity. Hypertrophy of chondrocytes was seen in all, but was more apparent in the PD, 
BD, and Sham groups. The hypertrophy of the chondrocytes is indicative of endochondral bone 
formation [59] [60]; hence the bone is undergoing remodeling process. In the PD groups at the 
crest of tibia, there was a mix of hypertrophic chondrocytes and a new bone matrix, which is 





was predominantly blue in the bone matrix of the tibia, the thickening of the periosteal side 
stained blue and the crest of tibia thickening in the PD, BD, PS, BS and Sham groups as well. 
This confirmed the presence of bone/collagenous tissue in these, where PD and PS showed the 
most bone formation at periosteal and crest of the tibia. The callus formation in the PD and BS 
groups had stained blue as well, which confirmed the presence of bone/collagenous tissue. 
Collagen type III plays a key role in tissue repair and healing process, which its presence 
regulates osteoblast differentiation and bone quantity [61], this supports the presence of collagen 
in callus and reactive areas of thickening is progressing to new bone formation and repair. PD, 
BS, PS, BS, and Sham groups all were positive for TRAP, where the PD showed the highest 
activity, followed by BD and PS. The PD showed a larger population of osteoclasts at the ROI 
and reactive callus in the marrow space in comparison to the BD group. This may be indicative of 
a higher turnover of remodeling of the ROI. [60]  The Sham and BS groups had displayed the 
smaller population of osteoclasts, which was found at the crest of tibia. Osteoclastic activity 
exists after 7 days after surgical intervention, confirming findings by Dibart et al. [1], Preti et al 
[7], Ohira et al. [18], and Kernitsky et al. [9]. The transcortical penetration of the tibia inflicted a 
greater biological response when compared to the shallow penetration groups. Whereas the PD 
and BD groups had active callus formation on Day 7 and the PS and BS group did not show any 
signs of callus formation in the ROI. The assumption is that the activation of the marrow MSCs 
along with the periosteal MSCs is necessary for progression of an accelerated or more profound 
remodeling process. The PS and BS group lacked the activation of the marrow cells, which could 








We observed that utilization of digital dentistry optimized the success of 
localizing the highly specific region of interest, instead of using a blind approach.  This 
optimization helped us reduce the need for additional surgeries if the specific ROI was 
not found in the specimen. Also, the use of the CBCT guided us in understanding the 
distance needed to cut the paraffin block to reach the ROI and the location and angulation 
of the lesion expected in the axial direction.  A clearer understanding of how the axial 
slice of the tibia at the ROI increased the confidence in preparation of the histological 
slide to review for the biological activity. 
The disruption of bone integrity by the two surgical modalities (bur and piezo) 
differed in their biological response.  As H.M Frost [40] had described that the disruption 
in the integrity of bone must be sufficient to initiate the phenomenon of RAP which will 
increase the healing and Yaffe et al. [56] described that a simple reflection of a full 
thickness flap was sufficient to invoke RAP in the underlying bone. In our experiment we 
observed supportive data correlating the thickening of the periosteal layer depicting 
activation of cells in the sham group, along with a greater response in the PD, BD, PS, 
and BS groups on Day 3. The reactive bone formation seen on Day 7 in all the 
experimental groups (except the Control) showed us, the thickening of the periosteum 
was initiating a response for bone formation. To isolate the effect of what effect the flap 
reflection was responsible for, the sham groups clarified this and coincides with the same 





et al [9] that depth of the intervention (transcortical vs. shallow penetration) as well plays 
a major role in the magnitude to which the RAP intensity occurs. We found that the 
transcortical penetration in both the PD and BD groups showed a faster transition from 
the early initiation phase (clot and fibrin mesh network) to the resorption phase, 
beginning as early as Day 3 but established at Day 7 in comparison to the PS and BS 
groups. When we compared the biological activity of PD and BD, the PD showed more 
disruption of the bone matrix adjacent to the ROI and the higher population of osteocytes 
undergoing apoptosis which in turn created a more profound activation of bone, which 
coincided with the piezoelectric effect in the canaliculi [17] to promote 
osteoclastogenesis and increase bone turnover. Therefore, the findings of this experiment 
confirmed what we had hypothesized, unfortunately to the restraints of time and COVID-
19 we were unable to investigate the increase in pressure within the bone, comparing Bur 
to Piezo and the exact magnitude of area affected from the piezoelectric knife, therefore 
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